文献速递外周动脉疾病

主髂动脉闭塞局限髂总动脉:内膜剥脱与旁路移植远期结局比较

Comparative Long-term Outcomes of Patients with Aortoiliac Occlusive Disease Limited to Common Iliac Arteries Who Underwent Endarterectomy versus Bypass Grafting.
PubMed 文献 · Ann Vasc Surg · 2020-05-29

单中心回顾性研究纳入2010–2019年主髂动脉闭塞局限髂总动脉的患者,比较主髂动脉血栓内膜剥脱术(AIE,13例)与主双髂动脉旁路移植术(ABIB,20例)。两组均安全有效,长期一期通畅率高,无需再干预;但ABIB组主要不良事件更多(4 vs 0)。

要点

  • 局限髂总动脉的主髂动脉闭塞,AIE与ABIB均安全有效。
  • 两组均恢复正常ABI并完全缓解症状,随访期无复发或再干预。
  • ABIB组主要不良事件多于AIE组(4 vs 0)。

核心结论

  • 对于病变局限于髂总动脉的主髂动脉闭塞患者,AIE与ABIB均安全有效,远期一期通畅率高且无需再干预。

研究设计与样本

  • 单中心回顾性分析,纳入2010–2019年前瞻性数据库中连续接受AIE或ABIB的主髂动脉闭塞患者,排除病变累及髂外动脉或股总动脉者。

主要发现

  • 两组心血管危险因素及AIOD严重程度无差异;AIE组BMI略高(30±5 vs. 26±6,P=0.06)。
  • 主要不良事件ABIB组4例、AIE组0例,包括肺炎、心肌梗死、血肿清除再手术及旁路移植物血栓切除加下肢血管造影各1例。
  • 两组ICU或住院时间无差异;均恢复正常ABI并完全缓解症状。
  • 平均随访AIE组43.4±25.2个月、ABIB组52.9±35.4个月,无复发症状或再干预;ABIB组2例死于非主动脉相关原因。

临床怎么用

  • 在严格选择病变局限于髂总动脉的患者时,AIE与ABIB均可作为安全有效的血运重建选项。
  • 需权衡ABIB组观察到的主要不良事件较多,个体化选择术式。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The objective of this study was to compared outcomes of patients with aortoiliac occlusive disease (AIOD), limited to the common iliac artery, who underwent either aortoiliac thromboendarterectomy (AIE) or aortobiiliac bypass grafting (ABIB). METHODS: A single-center, retrospective analysis of consecutive patients with AIOD who underwent either AIE or ABIB between 2010 and 2019 from a prospective database. Patients with disease extending to the external iliac or common femoral arteries were excluded. Data collected included demographics, cardiovascular risk factors, indication for surgery, preoperative and postoperative ankle brachial indexes (ABIs), estimated blood loss, major adverse events (MAEs), and long-term patency. The study end point was clinical success, defined as improvement in ABIs with resolution of symptoms. MAEs included return to the operating room for any reason, postoperative myocardial infarction, stroke, pneumonia, or venous thromboembolism. RESULTS: Thirty-three patients, who met inclusion criteria, underwent repair for AIOD (AIE: 13; ABIB: 20) at our institution during this time. In both groups, there were more women than men (AIE: 11, ABIB: 10) with a mean age of 55 ± 7 years and 58 ± 6 years in the AIE and ABIB group, respectively. Indication for surgery included disabling claudication in 19 patients, ischemic rest pain in 13 patients, and tissue loss in one patient. No difference in cardiovascular risk factors or AIOD severity was noted between groups. Patients in the AIE group had slightly higher body mass index (30 ± 5 vs. 26 ± 6, P = 0.06). Two patients in each group required concomitant renal/mesenteric artery endarterectomy. One patient in the AIE group required bilateral femoral artery exposure and external iliac thrombectomy. MAEs (4 vs. 0) were higher in the ABIB group including, pneumonia in one patient, myocardial infarction in another, return to the operating room for evacuation of hematoma in the third and bypass graft thrombectomy with lower extremity angiography in the fourth patient. There were no differences in the intensive care unit or hospital length of stay between groups. Patients in both groups achieved return of normal ABI and complete resolution of their symptoms. At mean follow-up time of 43.4 ± 25.2 and 52.9 ± 35.4 months in the AIE and ABIB group, respectively, there was no symptomatic recurrence or need for reintervention while two patients in the ABIB group died of non-aortic-related issues. CONCLUSIONS: Both procedures were safe, effective, and conferred high long-term primary patency with no need for reintervention in patients with AIOD limited to the common iliac arteries.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Manunga J, Mirza A, Skeik N, et al. Comparative Long-term Outcomes of Patients with Aortoiliac Occlusive Disease Limited to Common Iliac Arteries Who Underwent Endarterectomy versus Bypass Grafting. Ann Vasc Surg. 2020. PMID: 32474143. doi:10.1016/j.avsg.2020.05.043

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。